Effect of Short-term Oxygen During CPET in COPD
Phase 2
Completed
- Conditions
- Chronic Obstructive Pulmonary Disease
- Registration Number
- NCT03196089
- Lead Sponsor
- University of Zurich
- Brief Summary
In a randomized, sham-controlled trial the investigators will test whether supplemental oxygen given during cardiopulmonary exercise testing will improve exercise performance and physiological parameters in patients with chronic obstructive pulmonary disease.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
- diagnosis of chronic obstructive pulmonary disease
- on optimized medical therapy and in stable condition for at least 4 week
- desaturate in the 6 minute walking test by at least 4% to values <92%
Exclusion Criteria
- unstable conditions
- pregnant women
- patients with relevant concomitant lung disease and severe daytime hypoxemia
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Primary Outcome Measures
Name Time Method Watt 1 day Exercise time 1 day
- Secondary Outcome Measures
Name Time Method Ventilatory equivalent of carbon dioxide (VE/VCO2) slope 1 day Peak Oxygen uptake 1 day Respiratory Exchange ratio 1 day End-tidal pressures of carbon dioxide (PET CO2) 1 day Changes in arterial blood parameters 1 day
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie improved CPET capacity with short-term oxygen in hypoxemic COPD patients?
How does supplemental oxygen during CPET compare to standard bronchodilator therapy in COPD exercise tolerance?
Which biomarkers predict response to oxygen therapy during CPET in GOLD stage III/IV COPD patients?
What adverse events are associated with acute oxygen administration during CPET in hypercapnic COPD cohorts?
Are there synergistic effects of combining oxygen therapy with pulmonary rehabilitation during CPET in COPD?
Trial Locations
- Locations (1)
University Hospital Zurich, Division of Pneumology
🇨🇭Zürich, Switzerland
University Hospital Zurich, Division of Pneumology🇨🇭Zürich, Switzerland